Debbie Lin
InvestorPhD at DigitalDx Ventures
About
Digital health and life science investor currently VP of Strategic Partnerships at Caris Life Sciences, previously an Executive Director at Boehringer Ingelheim's Venture Fund over 14 years, and a lecturer at Stanford University School of Medicine. She holds a PhD in Pharmacogenomics and Bioinformatics from UCSF, a BS from Pomona College, and an MSc Eng from Stanford.
Colleagues at DigitalDx Ventures
Alissa Hsu Lynch
Investor at DigitalDx Ventures
Amit Goldman
Investor at DigitalDx Ventures
Anita Samarth
Investor at DigitalDx Ventures
Anula Jayasuriya
Investor at DigitalDx Ventures
Barbara Levy
Investor at DigitalDx Ventures
David Kirk
Investor at DigitalDx Ventures
Deborah DiSanzo
Investor at DigitalDx Ventures
Doug Ross
Investor at DigitalDx Ventures
Frequently asked questions
- Who is Debbie Lin?
- Digital health and life science investor currently VP of Strategic Partnerships at Caris Life Sciences, previously an Executive Director at Boehringer Ingelheim's Venture Fund over 14 years, and a lecturer at Stanford University School of Medicine. She holds a PhD in Pharmacogenomics and Bioinformatics from UCSF, a BS from Pomona College, and an MSc Eng from Stanford.
- Where does Debbie Lin work?
- Debbie Lin is PhD at DigitalDx Ventures.